Key facts
- This page summarizes Ann D. Rhoads's Form 4 filing for GLOBUS MEDICAL INC (GMED).
- 5 reported transactions and 2 derivative rows are listed below.
- Accepted by SEC: 17 Sep 2024, 16:34.
Ann D. Rhoads - 13 Sep 2024 Form 4 Insider Report for GLOBUS MEDICAL INC (GMED)
- Reporting relationship
- Director
- Issuer ticker
- GMED
- Reported as of
- 13 Sep 2024
- Net transaction value
- -$183,500
- SEC form
- 4
- Accepted by SEC
- 17 Sep 2024, 16:34:32 UTC
- Prior SEC filing
- 20 Jun 2024
- Next SEC filing
- 28 Mar 2025
- Source filing
- View source filing
- Reporting owner signature
- /s/ Kelly G. Huller, Attorney-in-Fact
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Ann D. Rhoads filed Form 4 for GLOBUS MEDICAL INC (GMED) on 17 Sep 2024.
Change
- Previous filing in this sequence was filed on 20 Jun 2024.
- Current net transaction value: -$183,500.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
GMED
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $361,500
- Shares
- +15,000
- Change %
- +66%
- Price
- $24.10
- Shares after
- 37,884
- Date
- 13 Sep 2024
- Ownership
- Direct
GMED
transaction
Class A Common Stock
Options Exercise
- Transaction value
- $510,400
- Shares
- +20,000
- Change %
- +53%
- Price
- $25.52
- Shares after
- 57,884
- Date
- 13 Sep 2024
- Ownership
- Direct
GMED
transaction
Class A Common Stock
Sale
- Transaction value
- $1,055,400
- Shares
- -15,000
- Change %
- -26%
- Price
- $70.36
- Shares after
- 42,884
- Date
- 13 Sep 2024
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
GMED
transaction
Derivative
Stock Option (Right to Buy Class A Common Stock)
Options Exercise
- Transaction value
- $0
- Shares
- -15,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 13 Sep 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 15,000
- Exercise price
- $24.10
- Footnotes
- F2
GMED
transaction
Derivative
Stock Option (Right to Buy Class A Common Stock)
Options Exercise
- Transaction value
- $0
- Shares
- -20,000
- Change %
- -100%
- Price
- $0.000000
- Shares after
- 0
- Date
- 13 Sep 2024
- Ownership
- Direct
- Underlying class
- Class A Common Stock
- Underlying amount
- 20,000
- Exercise price
- $25.52
- Footnotes
- F3
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 3 footnotes
Footnote F1
The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $70.10 to $70.53, inclusive. The reporting person undertakes to provide the Issuer, any security holder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the ranges set forth in footnote (1) to this Form 4.
Footnote F2
These options were granted on January 20, 2015 and are fully vested.
Footnote F3
These options were granted on January 25, 2016 and are fully vested.